ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations.

PURPOSE SNPs in chromosomal region 10q26 harboring PLEKHA1, ARMS2, and Htra1 showed the strongest association with age-related macular degeneration. Recent evidence suggests that in patients homozygous for the risk allele, the lack of synthesis of the poorly characterized ARMS2 is causative of this disorder. The present study was undertaken to gain an understanding of the genuine (patho)physiological role of this protein. METHODS ARMS2-interacting proteins were identified by using a yeast two-hybrid system and validated by coprecipitation. Immunofluorescence was applied to reveal the localization of ARMS2 in transfected cells and in human eyes. Western blot analyses were performed on extra- and intracellular fractions of ARMS2-expressing cells to demonstrate the secretion of ARMS2. RESULTS Contrary to previous reports, this study showed that ARMS2 is a secreted protein that binds several matrix proteins. Notably, ARMS2 directly interacts with fibulin-6 (hemicentin-1). Mutations in the fibulin-6 gene have been demonstrated to cause familial AMD. ARMS2 also interacts with further extracellular proteins, several of which have been implicated in macular dystrophies. Although ARMS2 apparently lacks any classic targeting sequence, it is translocated to the endoplasmic reticulum in cultured cells before secretion. ARMS2 is mostly confined to choroid pillars in human eyes, representing a part of extracellular matrix and corresponding to the principal sites of drusen formation. CONCLUSIONS The pivotal role of the extracellular matrix in the progression of AMD is underlined by the abnormal deposition of extracellular debris in the macula, observed frequently in affected individuals. The results have shown that ARMS2 may be necessary for proper matrix function.

[1]  J. Haines,et al.  Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. , 2009, Investigative ophthalmology & visual science.

[2]  R. Guymer,et al.  Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD). , 2009, Investigative ophthalmology & visual science.

[3]  R. Hogg,et al.  Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[4]  C. Klaver,et al.  The SERPING1 gene and age-related macular degeneration , 2008, The Lancet.

[5]  S. Ennis,et al.  Association between the SERPING1 gene and age-related macular degeneration: a two-stage case–control study , 2008, The Lancet.

[6]  S. Fisher,et al.  Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.

[7]  A. Negi,et al.  Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.

[8]  R. Kalluri,et al.  Basement Membrane Derived Fibulin-1 and Fibulin-5 Function as Angiogenesis Inhibitors and Suppress Tumor Growth , 2008, Experimental biology and medicine.

[9]  R. Roepman,et al.  A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes , 2007, Proteomics.

[10]  M. Stevenson,et al.  Mechanisms for Hsp70 secretion: crossing membranes without a leader. , 2007, Methods.

[11]  Takako Sasaki,et al.  Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. , 2007, Human molecular genetics.

[12]  E. Stone,et al.  The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. , 2007, Human molecular genetics.

[13]  Gonçalo R. Abecasis,et al.  A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration , 2007, Proceedings of the National Academy of Sciences.

[14]  R. Klein,et al.  Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. , 2007, Human molecular genetics.

[15]  J. Haines,et al.  Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. , 2007, Human molecular genetics.

[16]  W. Nickel Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2 , 2007, Journal of Cell Science.

[17]  Gary C. Brown,et al.  Age-related macular degeneration: the costs to society and the patient , 2007, Current opinion in ophthalmology.

[18]  H. Coxson,et al.  Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.

[19]  R. Timpl,et al.  A Comparative Analysis of the Fibulin Protein Family , 2007, Journal of Biological Chemistry.

[20]  S. Brunak,et al.  Locating proteins in the cell using TargetP, SignalP and related tools , 2007, Nature Protocols.

[21]  S. Fisher,et al.  Case–control genetic association study of fibulin‐6 (FBLN6 or HMCN1) variants in age‐related macular degeneration (AMD) , 2007, Human mutation.

[22]  S. Sivaprasad,et al.  Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration , 2007, Eye.

[23]  E. Stone,et al.  Fibulin-5 distribution in human eyes: relevance to age-related macular degeneration. , 2007, Experimental eye research.

[24]  A. Negi,et al.  The Upregulation of Angiogenic Gene Expression in Cultured Retinal Pigment Epithelial Cells Grown on Type I Collagen , 2007, Current eye research.

[25]  C. Barnstable,et al.  HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration , 2006, Science.

[26]  Jeremy Nathans,et al.  Macular degeneration: recent advances and therapeutic opportunities , 2006, Nature Reviews Neuroscience.

[27]  M. Ueffing,et al.  Identification and Functional Validation of Novel Autoantigens in Equine Uveitis* S , 2006, Molecular & Cellular Proteomics.

[28]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[29]  S. Fisher,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .

[30]  M. Ueffing,et al.  Proteomic analysis of the porcine interphotoreceptor matrix , 2005, Proteomics.

[31]  S. Sivaprasad,et al.  Serum elastin-derived peptides in age-related macular degeneration. , 2005, Investigative ophthalmology & visual science.

[32]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[33]  A. Bird,et al.  Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. , 2004, Investigative ophthalmology & visual science.

[34]  V. Sheffield,et al.  Missense variations in the fibulin 5 gene and age-related macular degeneration. , 2004, The New England journal of medicine.

[35]  Francis L. Munier,et al.  Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Is a Binding Partner of Epithelial Growth Factor-containing Fibulin-like Extracellular Matrix Protein 1 (EFEMP1) , 2004, Journal of Biological Chemistry.

[36]  R. Klein,et al.  Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. , 2004, American journal of human genetics.

[37]  P. Braghetta,et al.  EMILIN-1 Deficiency Induces Elastogenesis and Vascular Cell Defects , 2004, Molecular and Cellular Biology.

[38]  M. Klein,et al.  Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. , 2003, Human molecular genetics.

[39]  J. Bocco,et al.  In vivo expression of recombinant pregnancy‐specific glycoprotein 1a induces alternative activation of monocytes and enhances Th2‐type immune response , 2003, European journal of immunology.

[40]  R. Goodyear,et al.  An emilin family extracellular matrix protein identified in the cochlear basilar membrane , 2003, Molecular and Cellular Neuroscience.

[41]  R. Timpl,et al.  Fibulins: a versatile family of extracellular matrix proteins , 2003, Nature Reviews Molecular Cell Biology.

[42]  A. Colombatti,et al.  Isolation and Characterization of EMILIN-2, a New Component of the Growing EMILINs Family and a Member of the EMI Domain-containing Superfamily* , 2001, The Journal of Biological Chemistry.

[43]  H. Eng,et al.  Association of extracellular matrix proteins fibulin‐1 and fibulin‐2 with fibronectin in bone marrow stroma , 2000, British journal of haematology.

[44]  R. Timpl,et al.  Tropoelastin binding to fibulins, nidogen‐2 and other extracellular matrix proteins , 1999, FEBS letters.

[45]  R. Guymer,et al.  Changes in Bruch’s membrane and related structures with age , 1999, Progress in Retinal and Eye Research.

[46]  H. Larjava,et al.  MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? , 1998, Biochemical and biophysical research communications.

[47]  T. Matise,et al.  Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.

[48]  J. Felsenstein An alternating least squares approach to inferring phylogenies from pairwise distances. , 1997, Systematic biology.

[49]  B. Jungnickel,et al.  Approaching the mechanism of protein transport across the ER membrane. , 1996, Current Opinion in Cell Biology.

[50]  T. Sasaki,et al.  Binding of mouse and human fibulin-2 to extracellular matrix ligands. , 1995, Journal of molecular biology.

[51]  T Vogel,et al.  Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin , 1993, The Journal of cell biology.

[52]  G. G. Reid,et al.  Type IV collagen and laminin in Bruch's membrane and basal linear deposit in the human macula. , 1992, The British journal of ophthalmology.

[53]  J. Forrester,et al.  Factors affecting the migration and growth of endothelial cells from microvessels of bovine retina. , 1990, Experimental eye research.

[54]  W. Spellacy,et al.  Measurement of pregnancy-associated plasma proteins during human gestation. , 1974, The Journal of clinical investigation.

[55]  E. Rimm,et al.  A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. , 2007, Archives of ophthalmology.

[56]  T. Glant,et al.  Appearance and persistence of fibronectin in cartilage , 2004, Histochemistry.

[57]  K. Yeow,et al.  Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[58]  J. Martin,et al.  Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. , 2001, Journal of the American Society of Nephrology : JASN.

[59]  B S Hawkins,et al.  Epidemiology of age-related macular degeneration. , 1999, Molecular vision.